China Future Tech /
Biomedicine
Related Topics:
Companies
Policy
Science
Industry Trends
Geopolitics
Biomedicine
Hong Kong health tech: private-public alliance advances male HPV testing
Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.
17 Oct 2024 - 8:30AM
CK Life’s Yuen banks on Big Pharma experience to boost new drug success
8 Oct 2024 - 7:13PM
WuXi AppTec, WuXi Biologics rise in Hong Kong as some operations go up for sale
4 Oct 2024 - 6:00PM
China Business
Wuxi AppTec’s upbeat business update boosts stock despite US bill
A presentation persuaded investors that risk of a potential US blacklisting is low while growth in some business areas is ‘unprecedented’.
29 Sep 2024 - 4:15PM
Shares in Chinese drug research and development group Wuxi AppTec closed up 23.9 per cent on Friday, the most since its listing in 2018. Photo: Reuters
China Opinion
Opinion
|
Is biotech the next battleground in US-China decoupling?
With both countries viewing technological leadership as a zero-sum game, the risk of a fragmented global innovation ecosystem is growing.
25 Sep 2024 - 4:50PM
videocam
Science
China’s strides in academic research seen to narrow US lead in medical science
Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific publishers.
25 Sep 2024 - 4:14PM
videocam
39
Science
China-born scientist Chen Zhijian wins ‘America’s Nobel’ for medical research
Texas-based Chen wins Albert Lasker Award for discovery of enzyme cGAS, holding out ‘promise for fighting infectious diseases and cancer’.
25 Sep 2024 - 4:16PM
68
Science
China wants humans to live healthier, longer by sequencing 1% of world’s population
The proposed Human Genome Project II could set in motion a ‘paradigm shift’ toward more precise public health, and a global research alliance.
25 Sep 2024 - 4:15PM
videocam
Chinese researchers have initiated a plan to extend average health spans by improving medical practices such as screening tests for genetic diseases and rare disease diagnoses. Photo: Shutterstock
Science
Who is on the growing list of China-linked scientists under US investigation?
The targeting of scientists in the United States for suspected Chinese ties reached a peak in 2018 and continues to affect a very altered research environment.
6 Sep 2024 - 9:56AM
30
Politics
China targets hi-tech drug and medical equipment industries for support
State Council unveils plans to promote development in the areas over the next two years.
26 Aug 2023 - 10:00PM
videocam
9
Science
China Initiative left researchers feeling ‘targeted, alienated’, US agency says
The National Institutes of Health is taking steps to repair relations with Asian researchers, but damage is ‘long-lasting and almost irreversible’, scientist says.
26 Aug 2024 - 8:17PM
videocam
62
Science
Chinese diet shift to more meat to cost US$14 billion in health spending: study
Scientists say amid China’s healthcare system development and reform, ‘transitioning to a plant-based diet will be crucial’.
25 Sep 2024 - 4:17PM
videocam
20
Chinese researchers say the increased investment in healthcare as a result of dietary burden hinders “the economic progress of the country and its residents toward affluence”. Photo: Shutterstock Images
China
Senior US official lauds China cooperation on tech-transfer controls
‘End-use checks’ have improved since the pandemic, but pending congressional legislation is keeping mainland firms in limbo.
13 Sep 2024 - 4:47AM
videocam
6
Science
China’s Wuhan institute creates nasal Covid-19 vaccine for ‘future pandemics’
‘Broad spectrum’ nanovaccine can target multiple coronaviruses, says team at institute once in spotlight over Covid lab leak theory.
25 Sep 2024 - 4:20PM
videocam
Science
New nano-plant drug created for deadliest brain cancer by China-US team
A new nanoparticle treatment is showing promise for glioblastoma, one of the most aggressive forms of brain cancer.
25 Sep 2024 - 4:23PM
videocam
China
‘China week’ at US House puts biotech firms, Hong Kong offices in cross hairs
Most of the scheduled 28 items have bipartisan support and follow efforts to tackle national and economic security threats posed by Beijing.
10 Sep 2024 - 12:46AM
videocam
19
Various pieces of US legislation intended to blunt China’s influence and competitive edge are soon due for consideration in Washington. Photo: Shutterstock
Global Economy
Will medical tourists be the next to benefit from China’s visa-free push?
China is not generally considered a go-to option for healthcare and treatments, with the US, South Korea, Japan and Turkey already on the map.
25 Sep 2024 - 6:24PM
videocam
8
Science
Chinese researchers’ implant genetically modified brain cells for neuron growth
Gene sequence could be implanted with electrodes to make neurons larger and easier to ‘read’ in quest for better mind control of devices.
25 Sep 2024 - 4:36PM
videocam
Science
Chinese scientists say new hydrogel can treat most common type of arthritis
Material combining hydrogel microspheres and antibody targeting injured cartilage presents ‘promising’ technique for treating osteoarthritis.
25 Sep 2024 - 4:37PM
videocam
Diplomacy
Why US right-wing Project 2025 could be bad news for China if Trump wins
Heritage Foundation road map for a Trump-led government has its sights set on Beijing as it answers, ‘How we can take on China’.
25 Sep 2024 - 3:17PM
videocam
63
China needs to be prepared for the worst in terms of the US presidential election, as worries circulate over the contents of a Republican-led policy blueprint. Photo: Shutterstock
China Business
Chinese drugs giant, Shenzhen team up to invest in city’s biomedical start-ups
Fosun Pharma will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular biology, genetics and other fields related to biomedicine.
14 Mar 2024 - 7:00PM
videocam
China Business
Hong Kong stocks surrender rally as WuXi Bio slumps 21% while Tencent, Li Auto gain
Stocks declined, capping another week of losses, after WuXi Biologics suffered another major plunge. Market surrendered an earlier rally fuelled by favourable Beijing policy and robust EV deliveries in January.
2 Feb 2024 - 4:47PM
13
China Business
Hong Kong stocks rebound as WuXi Bio, Sands get support to stem market rout
Stocks rebound from a 13-month low, snapping a three-day slump. Some companies are quickly pushing for buy-backs to help stem losses and shore up market confidence.
6 Dec 2023 - 4:53PM
OPINION
Marina Yue Zhang
Opinion
|
Is biotech the next battleground in US-China decoupling?
25 Sep 2024 - 4:50PM
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW